Prevention Latest News Archive
The FDA has issued a warning regarding rare cases of ischemic and hemorrhagic stroke and cervicocephalic arterial dissection in patients with MS shortly after receiving Lemtrada.
Linagliptin added to usual care compared with placebo added to usual care resulted in a noninferior risk for a composite cardiovascular or renal outcome over a median 2.2 years.
HbA1c Variability in General Population Increases Risk for Cardiovascular Events, All-Cause Mortality
People who do not have diabetes or cardiovascular disease but have high hemoglobin A1c variability tend to be at greater risk for major adverse cardiovascular events and all-cause mortality.
Patients with splanchnic vein thrombosis may be at an increased risk for bleeding and arterial cardiovascular events for years after diagnosis.
PLWHIV who have received treatment had lower whole-brain standardized uptake values compared to healthy controls with risk for CVD as the best predictor.
This guidance, updated for the first time since 2008, provides evidence-based recommendations for children (ages 3-17) and adults.
Pregnancy loss was associated with a greater long-term risk for incident cardiovascular events.
Women entering menopause had patterns of cardiometabolic risk components related to race/ethnicity.
Employer-sponsored wellness programs can put physicians in an unenviable position.
Investigators examined the predictive accuracy of ERS-RA and compared it with a risk calculator without RA-specific risk factors in patients with new-onset RA.
There is a dose-dependent association between smoking and coronary heart disease in patients with type 1 diabetes.
A reduction in CVD risk was found with concomitant methotrexate and bDMARD use for rheumatoid arthritis.
Researchers analyzed how improvements in metabolic syndrome may impact the risk of developing type 2 diabetes and cardiovascular disease in patients with prediabetes.
Wide variations in influenza vaccine coverage have been noted across healthcare personnel based on occupation and worksite.
Patients initiating diclofenac may have an increased risk for cardiovascular events compared with individuals using paracetamol, other traditional nonsteroidal anti-inflammatory drugs (NSAIDs), or those not taking NSAIDs.
Exposure to abacavir is associated with an increased risk for cardiovascular disease in individuals infected with HIV.
Central obesity might not be an effective predictor for atherosclerotic cardiovascular disease events in older men.
The intent of the document is to help reduce heparin product overdose errors caused by misinterpretation of the drug strength displayed in the labeling.
Individual antiretroviral medications have been linked with changes in cardiac structure in youths with perinatally acquired HIV.
Current biologic use was associated with a reduction in major cardiovascular events in patients with inflammatory arthritis.
Cardiovascular risk within 30 days of therapy start was approximately 2-fold higher with the incident use of tiotropium in COPD.
To investigate the cardiovascular risks associated with diclofenac, researchers conducted a series of cohort studies mimicking the design criteria of a clinical trial.
Investigators examine whether age of onset of type 1 diabetes affects mortality and cardiovascular risk.
Identification of interleukin 6 receptor single-nucleotide polymorphisms was associated with a significantly reduced risk for aortic aneurysm phenotypes.
Treatment with xenon may improve functional outcomes and reduce mortality in cardiac arrest survivors.
Tissue adhesive with polyurethane dressing, bordered polyurethane dressing, or using a securement device with polyurethane dressing were not superior to standard low-cost polyurethane dressing for peripheral intravenous catheters.
Investigators sought to compare cardiovascular risk and disease prevalence in the Hispanic and Latina population in the United States with and without a history of gestational diabetes.
Approximately 1% of individuals in the United States have a genetic predisposition to cancer or heart disease, and these individuals could be ideal candidates for genetic screening.
Among US dialysis patients, cardiovascular event rates are highest in those with diabetic nephropathy and lowest among those with IgA nephropathy.
The American College of Cardiology and American Heart Association developed updated guidelines on the evaluation, management, and monitoring of adults with congenital heart disease.
Glucose concentration assessment before noncardiac surgery may help clinicians predict the risk for postoperative myocardial injury in patients with and without diabetes.
If Tybost is given with atazanavir or darunavir, coadministration with rivaroxaban is not recommended due to a potentially increased bleeding risk.
All physical activities (sports, cycling, and gardening) except walking were associated with a significant decreased risk for myocardial infarction.
Studies comparing MMT to buprenorphine maintenance treatment (BMT) over 5-years found buprenorphine to be a safer drug for opioid maintenance treatment as it had no significant effect on QT prolongation.
While approved in Europe, Asia, and Latin America, tianeptine, an opioid receptor agonist, is an unscheduled pharmaceutical agent in the US that has been linked to serious adverse events, including death, when used for recreational purposes.
The FDA aims to support the development of novel inhaled nicotine replacement therapies to combat the public health crisis of tobacco use in the United States.
Data indicate that drug-naive new onset systemic lupus erythematosus was likely to involve silent cardiac impairment.
This represents the prospective study confirming an independent relationship between cardiovascular mortality and oxidative DNA damage in type 2 diabetes.
Cesium chloride is not approved by the FDA to treat cancer or any other disease.
The relationship between circadian rhythm and sleep measures and components of metabolic syndrome in patients with bipolar disorder.
High BMI, low physical activity levels, and frequent smoking and high genetic risk increased the risk for atrial fibrillation, coronary artery disease, hypertension, stroke, and diabetes.
Investigators examined gender differences in baseline characteristics and outcomes in patients with t2d and ASCVD.
Insufficient evidence for adding to traditional cardiovascular disease risk assessment in asymptomatic adults.
The recall affects approximately 470,000 units that include drugs packaged with 3 to 10 tablets per blister card. The blister packs were developed for use in hospitals, however some were sent to retail pharmacies and were likely dispensed for in-home use.
Patients with these cardiovascular diseases would benefit from early psychiatric help.
The retrospective cohort study involved a search of Medicaid claims of pediatric patients aged 5 to 20 years who were initiated on atypical antipsychotic medications.
For this study, researchers searched several large databases (from 1980 to 2016) for randomized, controlled trials (RCTs) that compared clinical outcomes in patients on DAPT taking PPIs or H2RAs.
Significantly more coronary heart and cardiovascular disease hard events occurred in individuals with erectile dysfunction vs those without.
Nonsteroidal anti-inflammatory drug use mediated a substantial amount of cardiovascular disease risk in osteoarthritis.
According to the authors, this is the first study to identify medications most commonly reported for a specific adverse reaction using this database.
The United States Preventive Services Task Force does not recommend screening with resting or exercise electrocardiography in asymptomatic individuals at low risk for cardiovascular disease events.
An increased risk for cardiovascular disease with ritonavir-boosted darunavir regimens for HIV was identified in a prospective multicenter study.
Multiple studies have indicated that the 2013 PCEs - published by the American College of Cardiology/American Heart Association Task Force on Practice Guidelines - substantially misestimated CVD risk.
Perioperative major adverse cardiovascular and cerebrovascular events may be more common in patients with diabetes.
Patients taking celecoxib for arthritis who were at risk for cardiovascular events experienced better safety outcomes than with naproxen or ibuprofen.
The American Heart Association has reconfirmed their position on consuming fish rich in omega-3 fatty acids.
The approval of Retacrit was based on a review of evidence that included human pharmacokinetic/pharmacodynamic data and clinical immunogenicity data which demonstrated a high degree of similarity between Retacrit and its reference product.
An annual wellness exam performed by an OB/GYN can be used to evaluate a woman's heart health.
Investigators examined 6 biomarkers for predicting adverse cardiovascular outcomes in patients with type 2 diabetes.
Clinicians should take depression into careful consideration when treating patients with Alzheimer dementia, as the two conditions combined may predispose patients to cardiovascular disease more than either condition alone.
The rate of liquid nicotine exposure in children younger than 6 years of age has declined since 2015, but it continues to pose a serious poisoning risk.
There were no observable differences in the incidence of any cardiovascular events across the smoking cessation treatment groups.
In a wide ranging statement, the FDA commissioner Scott Gottlieb, MD, specifically targets novel nicotine-delivery products as being problematic since many of these devices resemble USB flash drives, have high nicotine levels and have emissions that are hard to see.
The American Heart Association provided updated guidelines for the routine assessment of physical activity for healthcare systems and providers as a way to prevent future health complications.
Biologic therapies for psoriasis may have an impact on cardiovascular parameters, potentially resulting in the occurrence of major adverse cardiovascular events.
Researchers examined whether menopausal symptoms, quality of life, and depression are related to arterial stiffness, a risk factor for cardiovascular disease.
New Class 1 recommendations involve the referral of inpatients and outpatients to cardiac rehabilitation programs that include exercise training.
Although varenicline was effective for short-term smoking cessation, more than half of the patients in the EVITA trial relapsed after 1 year.
Findings confirm that cardiovascular complications related to commonly-administered, live viral vaccination are rare in adults.
At 6 months, researchers found a negative association between electronic cigarette use and subsequent smoking cessation.
The FDA is seeking data, research, and general information regarding the role that flavors play in youth smoking.
For patients with type 2 diabetes, pioglitazone use may be associated with decreases in both cardiovascular and noncardiovascular mortality.
Positive emotions and low levels of depression after a CVD event are associated with low risk for mortality.
Use of sodium-glucose cotransporter inhibitors resulted in significant reductions in hemoglobin A1c, fasting blood glucose, and body weight.
Increasing coronary artery calcium correlated with increased CVD events, whereas increasing cardiorespiratory fitness tended to correlate with decreased CVD events.
Patients with rheumatoid arthritis and diabetes treated with abatacept may have a lower risk for myocardial infarction, stroke/transient ischemic attack, and coronary revascularization compared with tumor necrosis factor inhibitors.
Abstinence-contingent incentives improved smoking cessation outcomes among economically disadvantaged smokers with mental illness.
Smoke-free ordinances may reduce the number of lung cancer cases.
FDA released a safety alert that gout medication shows increased risk for heart-related death.
FDA releases safety alert that biotin can significantly interfere with certain lab tests and cause incorrect results which may go undetected.
Anti-inflammatory therapy with canakinumab may result in a significantly lower incidence of lung cancer and lung cancer mortality.
Adolescents who use e-cigarettes with higher concentrations of nicotine may be at risk for progressively increasing the frequency and intensity of smoking and vaping.
Certain factors have been associated with accelerated atherosclerosis in spondyloarthritis without overt cardiovascular disease.
Traditional risk factors for cardiovascular disease are linked to a higher risk of heart disease in HIV-positive premenopausal women than HIV itself.
Knowledge regarding the impact of various risk factors for cardiovascular disease (CVD) events is essential for the establishment of individualized risk evaluation and prevention.
Liraglutide has received approval by the US Food and Drug Administration for a new indication to reduce the risk of MACE in type 2 diabetes patients.
The American Heart Association has shifted its dietary recommendations from replacing total fat with carbohydrates to replacing saturated and trans fats with unsaturated fat.
Coronary heart disease risk may be increased in individuals who consume diets consisting of less healthy plant foods.
An overview of new USPSTF recommendations for behavioral lifestyle counseling for the prevention of cardiovascular disease plus an expert interview.
Opioid use increases cardiac event risk in older adults with chronic obstructive pulmonary disease.
The degree of risk for cardiometabolic events and all-cause mortality increased with nonsteroidal anti-inflammatory drugs and corticosteroid drugs.
Patients with rheumatoid arthritis and end-stage renal disease have an increased risk for CV-related and all cause mortality.
Mortality risk is increased in association to short sleep duration in cardiovascular disease and stroke.
New reports found that 70% of home blood pressure monitor readings are inaccurate.
Bristol-Myers Squibb is recalling one lot of Eliquis after finding that 1 of the bottles contained the wrong dosage.
Individuals who had the lowest levels of recommended physical activity had elevated levels of high-sensitivity cardiac troponin T.
A randomized double-blind placebo-controlled trial examined the relationship between high-dose oral vitamin D supplementation and reduced risk of cardiovascular disease.
There was a steep graded association between controlled cardiovascular risk factors and outcomes in patients with type 1 diabetes.
Increases in body weight fluctuations were associated with greater risk for coronary and cardiovascular events and death.
Periodontitis was associated with an increased mortality risk while edentulism was linked with an increased cardiovascular disease risk.
The Cardiology Advisor Articles
- Cardiac Troponin Elevation Predicts Major Adverse Events Even Without Specific Diagnosis
- How Has the Medicaid Expansion Affected Patients Hospitalized With Acute MI?
- Macitentan Not Superior to Placebo for Improving Exercise Capacity in Eisenmenger Syndrome
- Association Between Statins and Depression Likely Mediated by Confounding
- Occupational Metal, Pesticide Exposure May Be Associated With Increased CVD Risk
- ASH Develops Practice Guidelines for Venous Thromboembolism
- Tetralogy of Fallot: Long-Term Outcomes After Surgical Repair
- Cardiac Troponin Elevation Predicts Major Adverse Events Even Without Specific Diagnosis
- Catheter Ablation Superior to Drug Therapy for Atrial Fibrillation in Heart Failure
- Trends in Endocarditis Incidence After Implementation of 2007 AHA Recommendations
- Researchers Identify Golden Ratio Between Pulmonary Pressure Components in PAH
- FDA: Potential Increased Mortality With Paclitaxel-Coated Balloons, Stents for PAD
- Inhaled Dry Powder Formulation of Treprostinil Well Tolerated in PAH
- Elevated Myocardial T1 Associated With Increased Septal Angle in PAH
- Pulmonary Hypertension Intensive Care Options Depend on Treatment Goals